Samsara Bio Capital, LLC Novavax Inc Transaction History

Samsara Bio Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $122,365 - $265,125	21,244 New	21,244 $147,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $214,052 - $444,211	-5,900 Reduced 21.74%	21,244 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $405,832 - $657,397	-3,016 Reduced 10.0%	27,144 $3.88 Million
Q4 2020 Feb 17, 2021	BUY	$78.74 - $139.5 $669,290 - $1.19 Million	8,500 Added 39.24%	30,160 $3.36 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $1.72 Million - $3.87 Million	21,660 New	21,660 $2.35 Million

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.